Financials
- Market Capitalization 747.15 M
- Employee 102
- Founded 2010
- CEO Brian Stuglik
- Website www.verastem.com
- Headquarter Massachusetts, United States
- FIGI BBG001J2LSK5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.56
Rapporto prezzo/fatturato
17.31
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2581 | ANNX Annexon, Inc. - common stock | 3.96 USD | -1.49% | -5.94% | -0.25% | +35.15% | 750.73 M USD | ||
| 2587 | CADL Candel Therapeutics, Inc. - Common Stock | 9.78 USD | -1.61% | -5.23% | -6.05% | +54.02% | 748.35 M USD | ||
| 2598 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.65 USD | -1.79% | -5.71% | -16.67% | +14.58% | 734.18 M USD | ||
| 2604 | ACHV Achieve Life Sciences, Inc. - Common Shares | 7.06 USD | -4.72% | 0.00% | 0.00% | +129.97% | 726.49 M USD |